Novartis CEO Praises Lek's Performance in Generic Industry
Ljubljana, 5 March - The share of generic drugs in the United States has been on the increase, which is a good news for Lek, predicted Daniel Vasella, CEO of Swiss drug maker Novartis, which owns the Ljubljana-based company. Visiting Slovenia, Vasella met on Friday with the country's businessmen to brief them on trends in the pharmaceutical industry.
The rest of this news item is available to subscribers.
The news item consists of 1.071 characters (without spaces) or 205 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.